ACTUATE THERAPEUTICS, INC.
ACTUATE THERAPEUTICS, INC.
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||
Assets Current | |||||||||||||
Cash Equivalents At Carrying Value | 8 | 13 | 17 | 6 | 4 | 9 | 14 | 0 | |||||
Prepaid Expense And Other Assets Current | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | |||||
Assets Current | 9 | 14 | 17 | 7 | 4 | 9 | 14 | 1 | |||||
Deferred Costs | - | - | - | - | - | - | - | 1 | |||||
Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | - | - | |||||
Assets | 9 | 14 | 18 | 7 | 4 | 9 | 14 | 2 | |||||
Liabilities And Stockhold… | |||||||||||||
Liabilities Current | |||||||||||||
Accounts Payable Current | 1 | 2 | 1 | 3 | 3 | 2 | 2 | 6 | |||||
Other Accrued Liabilities Current | 3 | 4 | 4 | 5 | 5 | 6 | 6 | 7 | |||||
Convertible Notes Payable Current | - | - | - | - | - | - | - | 7 | |||||
Accrued Salaries Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |||||
Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities Current | 5 | 6 | 6 | 9 | 9 | 9 | 8 | 20 | |||||
Liabilities Noncurrent | |||||||||||||
Other Accrued Liabilities Noncurrent | - | - | - | - | - | 0 | 0 | 1 | |||||
Interest Payable Current And Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Accounts Payable Other Current And Noncurrent | - | - | - | - | 0 | 0 | 0 | 0 | |||||
Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | |||||
Liabilities | 5 | 6 | 7 | 10 | 10 | 9 | 9 | 22 | |||||
Stockholders Equity | |||||||||||||
Temporary Equity Carrying Amount Attributable To P… | - | - | - | - | - | 0 | 0 | 94 | |||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 164 | 163 | 161 | 142 | 134 | 132 | 131 | 6 | |||||
Retained Earnings Accumulated Deficit | -160 | -155 | -150 | -145 | -139 | -132 | -126 | -120 | |||||
Stockholders Equity | 4 | 8 | 11 | -3 | -5 | 0 | 5 | -114 | |||||
Liabilities And Stockholders Equity | 9 | 14 | 18 | 7 | 4 | 9 | 14 | 2 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | - | |||||
Temporary Equity Par Or Stated Value Per Share | - | - | - | - | - | 0 | 0 | 0 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Temporary Equity Shares Authorized | - | - | - | - | - | 0 | 0 | 33 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Temporary Equity Shares Issued | - | - | - | - | - | 0 | 0 | 25 | |||||
Temporary Equity Shares Outstanding | - | - | - | - | - | 0 | 0 | 25 | |||||
Common Stock Shares Authorized | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 267 | |||||
Common Stock Shares Issued | 24 | 23 | 23 | 20 | 20 | 20 | 20 | 24 | |||||
Temporary Equity Liquidation Preference | - | - | - | - | - | 0 | 0 | 125 | |||||
Shares Outstanding | 24 | 23 | 23 | 20 | 20 | 20 | 20 | 24 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -35.17% | -47.59% | - | - | - | - | - | - | - | - | - | - |
| 2025 | -8.20% | -32.48% | -25.61% | 0.24% | -15.09% | -18.98% | 25.00% | 2.55% | -19.90% | 1.76% | 15.42% | -11.01% |
| 2024 | - | - | - | 11.35% | 33.13% | 32.21% | 4.56% | -2.69% | 5.49% | -7.52% | 41.34% | 59.73% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
ACTUATE THERAPEUTICS, INC. (ACTU) — SEC Financial Statements & Analysis
ACTUATE THERAPEUTICS, INC. (ACTU) is a pharmaceutical preparations company, incorporated in DE. ACTUATE THERAPEUTICS, INC. trades on Nasdaq as: ACTU. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), ACTUATE THERAPEUTICS, INC. reported a Debt-to-Equity ratio of 1.35x, a Price-to-Book (P/B) ratio of 17.04 (TTM), at a market cap of $64.49M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- 1.35x
- P/B TTM
- 17.04
- Market Cap
- $64.49M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ACTUATE THERAPEUTICS, INC. in?
ACTUATE THERAPEUTICS, INC. (ACTU) operates in the Pharmaceutical Preparations industry.
What is ACTU's market cap?
ACTUATE THERAPEUTICS, INC. (ACTU) has a market capitalization of $64.49M as of 2026-03-31.
What exchange does ACTU trade on?
ACTUATE THERAPEUTICS, INC. (ACTU) trades on the Nasdaq.
Where is ACTUATE THERAPEUTICS, INC. incorporated?
ACTUATE THERAPEUTICS, INC. is incorporated in DE.